Breast Cancer Drug - Global Market Outlook (2017-2026)

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Breast Cancer Drug Market, By Type
5.1 Introduction
5.2 Mitotic Inhibitor
5.3 Aromatase Inhibitor
5.4 Hormonal rec
5.5 HER2 Inhibitor
5.6 Anti-Metabolites
5.7 CDK 4/6 Inhibitor

6 Global Breast Cancer Drug Market, By Drug
6.1 Introduction
6.2 Targeted Therapy Drugs
6.2.1 Ado-Trastuzumab Emtansine
6.2.2 Neratinib
6.2.3 Monoclonal Antibodies (mAbs)
6.2.3.1 Bevacizumab
6.2.3.2 Trastuzumab
6.2.3.3 Other Monoclonal Antibodies (mAbs)
6.2.4 Lapatinib
6.2.5 Tyrosine kinase inhibitors
6.3 Chemotherapy Drugs
6.3.1 Antimetabolites
6.3.1.1 Capecitabine
6.3.1.2 Gemcitabine
6.3.1.3 Fluorouracil
6.3.2 Anthracyclines
6.3.2.1 Epirubicin
6.3.2.2 Doxorubicin
6.3.3 Alkylating Agents
6.3.4 Neoadjuvant Chemotherapy
6.3.5 Adjuvant Chemotherapy
6.3.6 Taxanes
6.3.6.1 Docetaxel
6.3.6.2 Paclitaxel
6.3.7 Advanced Breast Cancer
6.3.8 Epothilones
6.4 Hormone Therapy Drugs
6.4.1 Ecstasy and Related Drug (ERD)
6.4.2 Selective Estrogen-Receptor Modulators (SERMs)
6.4.2.1 Tamoxifen
6.4.2.2 Toremifene
6.4.2.3 Raloxifene
6.4.3 Aromatase Inhibitors
6.4.3.1 Anastrozole
6.4.3.2 Letrozole
6.4.3.3 Megestrol
6.4.5 Luteinising Hormone-Releasing Hormone
6.4.6 Other Hormonal Therapies
6.4.6.1 Goserelin Acetate
6.4.6.2 Fulvestrant
6.4.6.3 Fluoxymesterone
6.5 Other Drugs

7 Global Breast Cancer Drug Market, By Distribution Channel
7.1 Introduction
7.2 Clinics
7.3 Online Pharmacies
7.4 Ambulatory Surgical Centers
7.5 Hospitals
7.6 Retail Pharmacies

8 Global Breast Cancer Drug Market, By Drug
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 South America
8.4.1 Argentina
8.4.2 Brazil
8.4.3 Venezuela
8.4.4 Chile
8.4.5 Peru
8.5 Middle East & Africa
8.5.1 UAE
8.5.2 Saudi Arabia
8.5.3 Qatar
8.5.4 Iran
8.5.5 South Africa
8.5.6 Rest of MEA

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Novartis AG
10.2 Celgene Corporation
10.3 Janssen Global Services LLC
10.4 Onyx Pharmaceuticals Inc.
10.5 AbbVie, Inc.
10.6 Eli Lilly and Company
10.7 Celldex Therapeutics
10.8 BioNumerik Pharmaceuticals, Inc.
10.9 AstraZeneca
10.10 Merck & Co., Inc.
10.11 Genzyme Corporation
10.12 MacroGenics, Inc.
10.13 F. Hoffmann-La Roche Ltd.
10.14 Biocon

List of Tables
1 Global Breast Cancer Drug Market Outlook, By Region (2016-2026)(US $MN)
2 Global Breast Cancer Drug Market Outlook, By Type (2016-2026)(US $MN)
3 Global Breast Cancer Drug Market Outlook, By Mitotic Inhibitor (2016-2026)(US $MN)
4 Global Breast Cancer Drug Market Outlook, By Aromatase Inhibitor (2016-2026)(US $MN)
5 Global Breast Cancer Drug Market Outlook, By Hormonal rec (2016-2026)(US $MN)
6 Global Breast Cancer Drug Market Outlook, By HER2 Inhibitor (2016-2026)(US $MN)
7 Global Breast Cancer Drug Market Outlook, By Anti-Metabolites (2016-2026)(US $MN)
8 Global Breast Cancer Drug Market Outlook, By CDK 4/6 Inhibitor (2016-2026)(US $MN)
9 Global Breast Cancer Drug Market Outlook, By Drug (2016-2026)(US $MN)
10 Global Breast Cancer Drug Market Outlook, By Targeted Therapy Drugs (2016-2026)(US $MN)
11 Global Breast Cancer Drug Market Outlook, By Ado-Trastuzumab Emtansine (2016-2026)(US $MN)
12 Global Breast Cancer Drug Market Outlook, By Neratinib (2016-2026)(US $MN)
13 Global Breast Cancer Drug Market Outlook, By Monoclonal Antibodies (mAbs) (2016-2026)(US $MN)
14 Global Breast Cancer Drug Market Outlook, By Lapatinib (2016-2026)(US $MN)
15 Global Breast Cancer Drug Market Outlook, By Tyrosine kinase inhibitors (2016-2026)(US $MN)
16 Global Breast Cancer Drug Market Outlook, By Chemotherapy Drugs (2016-2026)(US $MN)
17 Global Breast Cancer Drug Market Outlook, By Antimetabolites (2016-2026)(US $MN)
18 Global Breast Cancer Drug Market Outlook, By Anthracyclines (2016-2026)(US $MN)
19 Global Breast Cancer Drug Market Outlook, By Alkylating Agents (2016-2026)(US $MN)
20 Global Breast Cancer Drug Market Outlook, By Neoadjuvant Chemotherapy (2016-2026)(US $MN)
21 Global Breast Cancer Drug Market Outlook, By Adjuvant Chemotherapy (2016-2026)(US $MN)
22 Global Breast Cancer Drug Market Outlook, By Taxanes (2016-2026)(US $MN)
23 Global Breast Cancer Drug Market Outlook, By Advanced Breast Cancer (2016-2026)(US $MN)
24 Global Breast Cancer Drug Market Outlook, By Epothilones (2016-2026)(US $MN)
25 Global Breast Cancer Drug Market Outlook, By Hormone Therapy Drugs (2016-2026)(US $MN)
26 Global Breast Cancer Drug Market Outlook, By Ecstasy and Related Drug (ERD) (2016-2026)(US $MN)
27 Global Breast Cancer Drug Market Outlook, By Selective Estrogen-Receptor Modulators (SERMs) (2016-2026)(US $MN)
28 Global Breast Cancer Drug Market Outlook, By Aromatase Inhibitors (2016-2026)(US $MN)
29 Global Breast Cancer Drug Market Outlook, By Luteinising Hormone-Releasing Hormone (2016-2026)(US $MN)
30 Global Breast Cancer Drug Market Outlook, By Other Hormonal Therapies (2016-2026)(US $MN)
31 Global Breast Cancer Drug Market Outlook, By Distribution Channel (2016-2026)(US $MN)
32 Global Breast Cancer Drug Market Outlook, By Clinics (2016-2026)(US $MN)
33 Global Breast Cancer Drug Market Outlook, By Online Pharmacies (2016-2026)(US $MN)
34 Global Breast Cancer Drug Market Outlook, By Ambulatory Surgical Centers (2016-2026)(US $MN)
35 Global Breast Cancer Drug Market Outlook, By Hospitals (2016-2026)(US $MN)
36 Global Breast Cancer Drug Market Outlook, By Retail Pharmacies (2016-2026)(US $MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.